Gabapentin
- Product NDC
- 67046-229
- 11-digit product format
- 670460229
- Labeler code
- 67046
- Product ID
- 67046-229_5a963df3-4c2c-71ce-e053-2a91aa0a1501
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Contract Pharmacy Services-PA
- Application
- ANDA077662
- Marketing category
- ANDA
- Marketing start
- 2017-10-02
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 800 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 67046-229-07 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-33d2-a426-e053-dadaa90af4c2 | 229 Gabapentin 800 mg These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 |
| 67046-229-14 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-33d2-a426-e053-dadaa90af4c2 | 229 Gabapentin 800 mg These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 |
| 67046-229-15 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-33d2-a426-e053-dadaa90af4c2 | 229 Gabapentin 800 mg These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 |
| 67046-229-20 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-33d2-a426-e053-dadaa90af4c2 | 229 Gabapentin 800 mg These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 |
| 67046-229-21 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-33d2-a426-e053-dadaa90af4c2 | 229 Gabapentin 800 mg These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 |
| 67046-229-28 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-33d2-a426-e053-dadaa90af4c2 | 229 Gabapentin 800 mg These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 |
| 67046-229-30 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-33d2-a426-e053-dadaa90af4c2 | 229 Gabapentin 800 mg These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 |
| 67046-229-60 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-33d2-a426-e053-dadaa90af4c2 | 229 Gabapentin 800 mg These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 |
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67046-229 | GABAPENTIN TABLET [CONTRACT PHARMACY SERVICES-PA] | 1 | Legacy NDC, 8 package rows | 20171003_5a963df3-4c2b-71ce-e053-2a91aa0a1501.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67046-229-07 | 67046022907 | 7 TABLET in 1 BLISTER PACK (67046-229-07) | 7 tablet | 2017-10-02 | 0000-00-00 | No | No | Current |
| 67046-229-14 | 67046022914 | 14 TABLET in 1 BLISTER PACK (67046-229-14) | 14 tablet | 2017-10-02 | 0000-00-00 | No | No | Current |
| 67046-229-15 | 67046022915 | 15 TABLET in 1 BLISTER PACK (67046-229-15) | 15 tablet | 2017-10-02 | 0000-00-00 | No | No | Current |
| 67046-229-20 | 67046022920 | 20 TABLET in 1 BLISTER PACK (67046-229-20) | 20 tablet | 2017-10-02 | 0000-00-00 | No | No | Current |
| 67046-229-21 | 67046022921 | 21 TABLET in 1 BLISTER PACK (67046-229-21) | 21 tablet | 2017-10-02 | 0000-00-00 | No | No | Current |
| 67046-229-28 | 67046022928 | 28 TABLET in 1 BLISTER PACK (67046-229-28) | 28 tablet | 2017-10-02 | 0000-00-00 | No | No | Current |
| 67046-229-30 | 67046022930 | 30 TABLET in 1 BLISTER PACK (67046-229-30) | 30 tablet | 2017-10-02 | 0000-00-00 | No | No | Current |
| 67046-229-60 | 67046022960 | 60 TABLET in 1 BLISTER PACK (67046-229-60) | 60 tablet | 2017-10-02 | 0000-00-00 | No | No | Current |